High-Flow Nasal Oxygyen Therapy During Sedated Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration(EBUS-TBNA)

ConditionsHigh Flow Oxygen Therapy ENDOBRONCHIAL ULTRASOUND - TRANSBRONCHIAL NEEDLE ASPIRATION Sedation Sedation Complication Blood Gas Analysis

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

About this trial

This study aims to evaluate the effects of high-flow nasal oxygen therapy on respiratory complications, blood gas parameters, and post-procedural recovery in patients undergoing sedated endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). Participants will be assigned to receive either high-flow nasal oxygen therapy or conventional oxygen therapy during the procedure. The incidence of respiratory complications, blood gas changes, and recovery outcomes will be compared between the two groups.

Eligibility criteria

Qualifiers

None

Disqualifiers

Age <18 years.

Pregnancy.

Requirement for endotracheal intubation or general anesthesia.

Severe hemodynamic instability.

Trial design

Treatments tested in this trial

High-Flow Nasal Oxygen Therapy
Conventional Oxygen Therapy

Treatment groups

120 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Lead sponsor

Source ClinicalTrials.gov